Click here to

  1. Home
  2. Meeting Program
  3. Keywords

Search by Keywords

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

3 | A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | show all

Keywords: radioimmunotherapy
PO-GePV-M-291A Semi-Supervised Learning Method Using Soft-Label for Cell Nuclei Segmentation On Immunohistochemistry Images
J Zhou1*, Z Yan2, J Polf3, H Zhang4, B Zhang5, M MacFarlane6, D Han7, M Zakhary8, A Gopal9, J Xu10, S Lee11, H Xu12, G Lasio13, S Chen14, (1) University of Maryland Shore Medical Center at Easton, Easton, MD, (2) Sense Brain, Princeton, NJ,(3) University of Maryland School of Medicine, Baltimore, MD, (4) University of Maryland School of Medicine, Baltimore, MD, (5) University of Maryland School of Medicine, Baltimore, MD, (6) University of Maryland School of Medicine, Baltimore, MD, (7) University of Maryland School of Medicine, Baltimore, MD, (8) University of Maryland School of Medicine, Baltimore, MD, (9) University of Maryland School of Medicine, Baltimore, MD, (10) University of Maryland School of Medicine, Baltimore, MD, (11) University of Maryland School of Medicine, Baltimore, MD, (12) University of Maryland School of Medicine, Baltimore, MD, (13) University of Maryland School of Medicine, Baltimore, MD, (14) University of Maryland School of Medicine, Baltimore, MD
PO-GePV-T-15A Machine Learning Prognostic Model for the Assessment of 177-Lu-DOTATATE Therapy Using Dose and Radiomics Features Analysis
D Plachouris1, V Eleftheriadis2, T Nanos1, P Papadimitroulas2, L Vergnaud3, N Papathanasiou4, D Sarrut3, G C Kagadis1*, (1) Department of Medical Physics, School of Medicine, University of Patras, Rion, GR,(2) Bioemission Technology Solutions - BIOEMTECH, Athens, GR, (3) CREATIS, CNRS, Universite de Lyon, Lyon, FR, (4) Department of Nuclear Medicine, School of Medicine, University of Patras, Rion, GR
PO-GePV-T-436Cell Morphometry for Advancing Nanoparticle-Mediated Radiotherapy Against Glioblastoma
E Jank*, O Salas, A Benoit, Y Walter, A Hubbard, A Ekpenyong, Creighton University, Omaha, NE, USA.
SU-K-206-7Targeted MR Contrast Nanoparticles for Programmed Death Ligand-1 Expression
N Brown1,2*, G Bort3,4, P Rocchi3,4, L Carmes3,4, M Iyer1,2, T Doussineau3, F Lux3,4, J Schoenfeld2, M Dougan5, O Tillement3,4,6, R Berbeco2, (1) Northeastern University, Department of Physics Boston, MA, (2) Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Department of Radiation Oncology, Boston, MA,(3) NHTherAguix, Lyon, France, (4) Universite Claude Bernard, Lyon, France, (5) Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA,(6) Institut Lumie`re-Matie`re, UMR 5306, Universite Lyon1-CNRS, Universite de Lyon, Villeurbanne Cedex, France
TU-D1030-IePD-F4-1Radiosensitizationeffect and Therapeutic Benefits of Small Sized Gold Nanoparticles
S Yasmin-Karim1Brigham and Women's Hospital, U Ibeh2, M Moreau3*, N Bih4, U Ngwa5, B Ziberi6, R Kumar7, G Makrigiorgos8, W Ngwa9, (1) Brigham and Women's Hospital, Boston, MA, (2) University of Massachusetts Boston, Boston, MA, (3) Johns Hopkins University, Columbia, MD, (4) Johns Hopkins University, Boston, MA, (5) Libertas Scholars Inc, ,,(6) University of Tetova, Tetova, Republic of North Macedonia, Boston, MA, (7) West Pharmaceutical Services, Inc., ,,(8) Dana Farber Cancer Institute, Boston, MA, (9) Johns Hopkins University, Boston, MA
WE-E-BRA-1Advancing Radioimmunotherapy For Brain Tumors Using In Vitro Assays
Y Walter*, O Salas, A Benoit, D Jordan, E Jank, A Hubbard, A Ekpenyong, Creighton University, Omaha, NE

Share:

Additional Links